Brian I Carr1, Vito Guerra. 1. Department of Nutritional Carcinogenesis, IRCCS S. de Bellis, National Institute for Digestive Diseases, Via Turi 27, 70013, Castellana Grotte, BA, Italy. brianicarr@hotmail.com
Abstract
BACKGROUND: Thrombocytopenia has been reported to be both a risk factor for hepatocellular carcinoma (HCC) development as well as a prognostic factor. Many HCCs also occur in presence of normal platelets. AIM: To examine a cohort of HCC patients with associated thrombocytosis. METHODS: Records were examined of a cohort of 634 biopsy-proven and randomly presenting HCC patients without thrombocytopenia. RESULTS: In the total cohort, 52 patients were identified with thrombocytosis (platelet levels >400 × 10(9)/L) and compared with 582 patients with normal platelet values. The average tumor sizes were 13.1 versus 8.8 cm (p < 0.0001), and their total average bilirubin levels were 0.9 versus 1.5 (p = 0.02), comparing thrombocytosis patients versus normal platelet count HCC patients. These differences were even more pronounced in patients with HCC sizes >5 cm. Thrombocytosis patients were younger and had less cirrhosis, but similar percent with hepatitis B or C or alcohol consumption. CONCLUSION: Thrombocytosis in association with HCC occurs in patients with larger tumor sizes and better liver function.
BACKGROUND:Thrombocytopenia has been reported to be both a risk factor for hepatocellular carcinoma (HCC) development as well as a prognostic factor. Many HCCs also occur in presence of normal platelets. AIM: To examine a cohort of HCCpatients with associated thrombocytosis. METHODS: Records were examined of a cohort of 634 biopsy-proven and randomly presenting HCCpatients without thrombocytopenia. RESULTS: In the total cohort, 52 patients were identified with thrombocytosis (platelet levels >400 × 10(9)/L) and compared with 582 patients with normal platelet values. The average tumor sizes were 13.1 versus 8.8 cm (p < 0.0001), and their total average bilirubin levels were 0.9 versus 1.5 (p = 0.02), comparing thrombocytosispatients versus normal platelet count HCCpatients. These differences were even more pronounced in patients with HCC sizes >5 cm. Thrombocytosispatients were younger and had less cirrhosis, but similar percent with hepatitis B or C or alcohol consumption. CONCLUSION:Thrombocytosis in association with HCC occurs in patients with larger tumor sizes and better liver function.
Authors: Min Soon Cho; Justin Bottsford-Miller; Hernan G Vasquez; Rebecca Stone; Behrouz Zand; Michael H Kroll; Anil K Sood; Vahid Afshar-Kharghan Journal: Blood Date: 2012-09-10 Impact factor: 22.113
Authors: Anna S Lok; Leonard B Seeff; Timothy R Morgan; Adrian M di Bisceglie; Richard K Sterling; Teresa M Curto; Gregory T Everson; Karen L Lindsay; William M Lee; Herbert L Bonkovsky; Jules L Dienstag; Marc G Ghany; Chihiro Morishima; Zachary D Goodman Journal: Gastroenterology Date: 2008-09-18 Impact factor: 22.682
Authors: S Truant; E Boleslawski; A Duhamel; A-F Bouras; A Louvet; C Febvay; E Leteurtre; G Huet; P Zerbib; S Dharancy; M Hebbar; F-R Pruvot Journal: Eur J Surg Oncol Date: 2012-08-03 Impact factor: 4.424
Authors: Bernhard Scheiner; Martha Kirstein; Sabine Popp; Florian Hucke; Simona Bota; Nataliya Rohr-Udilova; Thomas Reiberger; Christian Müller; Michael Trauner; Markus Peck-Radosavljevic; Arndt Vogel; Wolfgang Sieghart; Matthias Pinter Journal: Liver Cancer Date: 2018-06-22 Impact factor: 11.740
Authors: Hayam M Sayed; Mahmoud M Said; Nadia Y S Morcos; Mona A El Gawish; Amel F M Ismail Journal: Integr Cancer Ther Date: 2021 Jan-Dec Impact factor: 3.279